Stocks
Aravive, Inc.ARAV
NASDAQHealthcareBiotechnology$0.04-13.39%
A clinical-stage biotechnology company focused on developing targeted therapies for cancer and other serious diseases, with its lead programs aimed at inhibiting the GAS6/AXL signaling pathway linked to tumor growth and metastasis. The company’s pipeline has centered on batiraxcept, an investigation...
Market Cap: $2.9M52W Range: $0.04 – $2.46
This page tracks all publicly disclosed congressional trades in Aravive, Inc. (ARAV), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-28 | BOB GIBBS | sell | $158+ |